---
acquisition_date: '2025-10-21T16:20:55.323169'
acquisition_method: paperscraper_automated
audience:
- professional
- researcher
authors: '[''William UMeyerson'', ''Eric LRoss'', ''Chris JKennedy'', ''Rick HHoyle'',
  ''JagpreetChhatwal'', ''Philip SWang'', ''Jordan WSmoller'']'
conditions: []
content_type: research_paper
doi: 10.4088/JCP.25m15863
journal: The Journal of clinical psychiatry
keywords:
- mental_health
- neurochemistry
- pubmed
patient_friendly: false
primary_category: neurochemistry/other-neurotransmitters
publication_date: '2025-09-26'
reading_level: academic
search_priority: standard
search_query: neurotransmitter neurodevelopmental
search_tags:
- mental_health
- neurochemistry
- pubmed
- research
- academic
source: PUBMED via Paperscraper
title: 'Aripiprazole or Bupropion Augmentation Versus Switching to Bupropion in Treatment-Resistant
  Depression: A Risk-Benefit Analysis.'
topics:
- mental_health
type: research_paper
---

# Aripiprazole or Bupropion Augmentation Versus Switching to Bupropion in Treatment-Resistant Depression: A Risk-Benefit Analysis.

**Authors:** ['William UMeyerson', 'Eric LRoss', 'Chris JKennedy', 'Rick HHoyle', 'JagpreetChhatwal', 'Philip SWang', 'Jordan WSmoller']

**Journal:** The Journal of clinical psychiatry

**Publication Date:** 2025-09-26

**DOI:** 10.4088/JCP.25m15863

## Abstract



---

## Research Details

**Source:** PUBMED
**Category:** neurochemistry
**Primary Topics:** mental_health
**Search Query:** neurotransmitter neurodevelopmental
**Acquisition Date:** 2025-10-21

*This paper was automatically acquired and processed for the neurodevelopmental disorders knowledge base.*
